What to Do When Radioactive Iodine Therapy Does Not Achieve Hypothyroidism in Graves' Disease
Radioactive iodine (RAI) therapy is a common first-line intervention for Graves' disease, with the clinical goal of rendering the patient hypothyroid. When that outcome is not achieved within the expected timeframe, a different therapeutic pathway is indicated.
Prior Treatment — Target Not Reached
Radioactive iodine (RAI) therapy was used, targeting hypothyroidism over a period of six weeks to six months. When this endpoint is not reached, escalation to the next treatment line is appropriate.
Next-Line Approach — Partial Overview
The next line involves a definitive surgical intervention for the thyroid. Prior to the procedure, a preparatory phase using antithyroid drug therapy is required to achieve a specific clinical threshold. The complete protocol — including sequencing, clinical decision points, and the criteria for proceeding — is available via the full regimen.
Pre-operative clinical goal: Euthyroidism must be established before surgery proceeds — this is a required milestone under the protocol.
References
- Patients selecting thyroidectomy to treat GD should first be rendered euthyroid using ATDs.
- This typically requires 1–3 months of ATDs prior to thyroidectomy.
DOI: 10.1016/j.ecl.2021.12.004.
View source ↗